Active Partners
A consumer-focused investment firm backing founder-led brands and technologies from early stage through growth, with healthier living and wellness among its published themes.
- Focus
- Consumer brands + technology
- Stage
- Early stage through growth
- Early cheque
- £200,000–£1,000,000
- Growth cheque
- £5,000,000–£15,000,000 average
Who they back
Overview
Active Partners is a London investment firm focused exclusively on the consumer economy. It invests at early stage and growth stage, looking for founder-led brands and technologies with a differentiated proposition, strong customer engagement and potential to grow across markets.
Healthier living and wellness sits alongside education, responsible consumption and experiences within its consumer-investment focus.
At a glance
- Best suited to
- Founder-led consumer businesses
- Active looks for a distinct product edge, engaged customers, ambitious founders, values and rapid-growth potential.
- Investment stages
- Early stage and growth
- The firm publishes separate criteria and cheque ranges for the two routes.
- Health relevance
- Healthier living and wellness theme
- Active said the theme represented 38% of its 2024 deals, including ARTAH, Healf, Mojo, OurRitual, Coopah and P.Happi.
- Current vehicle
- Not publicly named
- The last independently confirmed vehicle is the £100,000,000 Active Partners III, which closed in 2020. That close does not show which vehicle or capital is available today.
- Focus
- Consumer brands + technology
- Stage
- Early stage through growth
- Early cheque
- £200,000–£1,000,000
- Growth cheque
- £5,000,000–£15,000,000 average
- Founded
- Founded in 2004
- Footprint
- London · early stage and growth
- Consumer footprint
- Founder capital and growth support
- Published prices
- £200,000–£1,000,000 early stage · £5,000,000–£15,000,000 average growth cheque
Company claims
Support for consumer-brand growth
Active Partners says it supports founders of consumer brands through growth and global expansion.
Founder pathways
Investment routes
Choose the route by company stage and capital need, then use the portfolio and team records to test fit before making contact.
Early-stage investment
For early-stage businesses reshaping the consumer economy, including the platforms that power consumer brands.
£200,000–£1,000,000Review the early-stage routeGrowth investment
For businesses with strong product-market fit, high customer engagement and the potential for rapid growth, including companies not yet at breakeven.
Average £5,000,000–£15,000,000Review the growth routePortfolio review
Use the portfolio filters and company stories to see how Active's thesis appears across stages, sectors and past outcomes.
PublicExplore the portfolioEarly-stage lead
Profumo leads the early-stage fund and names healthcare and education among his areas of interest.
Professional contact routeMeet the early-stage lead
Early-stage investment
Capital and fit
The ranges below come from Active's approach page as read on 31 August 2026; final terms depend on the company and round.
Early-stage investment
Mission-driven consumer brands and technology
For early-stage businesses reshaping the consumer economy, including the platforms that power consumer brands.
Availability: available
Link verified
Growth investment
Capital and fit
The ranges below come from Active's approach page as read on 31 August 2026; final terms depend on the company and round.
Growth investment
High-growth consumer businesses
For businesses with strong product-market fit, high customer engagement and the potential for rapid growth, including companies not yet at breakeven.
Availability: available
Link verified
Portfolio review
Capital and fit
The ranges below come from Active's approach page as read on 31 August 2026; final terms depend on the company and round.
Portfolio review
Current and exited company record
Use the portfolio filters and company stories to see how Active's thesis appears across stages, sectors and past outcomes.
Availability: available
Link verified
Early-stage lead
Capital and fit
The ranges below come from Active's approach page as read on 31 August 2026; final terms depend on the company and round.
Early-stage lead
Tom Profumo · Partner
Profumo leads the early-stage fund and names healthcare and education among his areas of interest.
Availability: available
Link verified
- Early-stage investmentPrice not published
For professionals
For early-stage businesses reshaping the consumer economy, including the platforms that power consumer brands. · £200,000–£1,000,000
Review the early-stage routeLink verifiedServiceProfessional Service
- Growth investmentPrice not published
For professionals
For businesses with strong product-market fit, high customer engagement and the potential for rapid growth, including companies not yet at breakeven. · Average £5,000,000–£15,000,000
Review the growth routeLink verifiedServiceProfessional Service
- Portfolio reviewPrice not published
For professionals
Use the portfolio filters and company stories to see how Active's thesis appears across stages, sectors and past outcomes. · Public
Explore the portfolioLink verifiedServiceReport
- Early-stage leadPrice not published
For professionals
Profumo leads the early-stage fund and names healthcare and education among his areas of interest. · Professional contact route
Meet the early-stage leadLink verifiedServiceProfessional Service
Investor profile
- Investor type
- multi strategy
- Current activity state
- Active as of 31 August 2026 check
- Investor type and current vehicle
- Active publishes separate early-stage and growth routes. The most recent independently confirmed vehicle located was the £100,000,000 Active Partners III close announced in 2020; the site does not identify a newer current vehicle. (not publicly stated)
- Investment thesis
- Founder-led consumer brands with a distinct edge and strong engagementSource
- The firm says it backs category-defining consumer brands and technologies with differentiated products, customer engagement, ambitious founders, growth potential, values and global ambition. (verified public)
- Sector and business model focus
- Healthier living and wellness is one published theme rather than the whole portfolio. Active's 2024 review says the theme represented 38% of that year's deals. (verified public)
- Stage and ownership strategy
- Early stage and growthSource
- The early-stage route covers mission-driven brands, consumer technologies and enabling platforms. The growth route is for consumer businesses with product-market fit, strong engagement and rapid-growth potential, including businesses not yet at breakeven. (verified public)
- Geography
- Active operates from London and asks founders to have global ambition, but its public approach page does not publish a complete list of eligible countries or founder domiciles. (not publicly stated)
- Check size or truthful capital path
- £200,000–£1,000,000 early stage; £5,000,000–£15,000,000 average growth chequeSource
- These are the cheque ranges published on Active's current approach page. They describe two different investment routes and should not be treated as a promise for an individual round. (verified public)
- Relevant portfolio and exits
- Active's current portfolio includes Healf, ARTAH, Mojo, P.Happi and Coopah. The site separately labels growth, early-stage and exited investments, helping founders distinguish current examples from historical outcomes. (verified public)
- Team and decision makers
- Active identifies Profumo as a partner who leads its early-stage fund and is particularly interested in healthcare and education. The wider team page lists the firm's current partners, investors and operating staff. (verified public)
- Founder support and value add
- Strategy, operational scaling, talent and consumer-sector supportSource
- The firm describes support with strategy, operating infrastructure, organizational scaling, senior talent and access to consumer operators, while leaving day-to-day management with the company. (verified public)
- Approach or introduction path
- On 31 August 2026 the approach page invited early-stage founders to get in touch, and individual team pages gave direct professional contact routes. No standardized application form or published diligence timetable was found. Re-confirm the contact route before approaching. (verified public, 31 August 2026)
- Current investing status
- On 31 August 2026 the site published early-stage and growth criteria, a current team, portfolio additions and recent investment news. The live vehicle, available allocation and submission route were not re-confirmed after that date; confirm them directly for a live raise. (verified public, 31 August 2026)
- Independent context and conflicts
- Companies House lists Active Partners Investments LLP as active and incorporated in 2004. British Patient Capital independently documented its £30,000,000 commitment to the £100,000,000 Active Partners III fund. (verified public)
What shapes a fit
Investment approach
The firm describes a consistent consumer lens across early-stage and growth investing.
Distinctive proposition
An edge
Active looks for brands with a clear point of view and a product that changes the consumer experience.
Demand signal
Customer engagement
Community, advocacy and repeat engagement are central to the firm's view of durable consumer brands.
Leadership
Visionary founders
Active emphasizes founder purpose, ambition and the drive to build a defining business.
Scale
Growth and global ambition
The firm seeks rapid-growth potential and offers support with market entry, organizational scaling and senior talent.
Eligible geographies and a current fund allocation by market are not published.
Stage + geography
Where the capital fits
Public criteria answer stage and cheque size more clearly than geography or current vehicle capacity.
- Early stage
- £200,000–£1,000,000
- Mission-driven brands, consumer technologies and enabling platforms.
- Growth
- Average £5,000,000–£15,000,000
- Rapid-growth consumer businesses with product-market fit and high customer engagement.
- Base
- London
- The firm asks companies to have global ambition but does not publish a complete list of eligible founder domiciles.
- Current capital
- Confirm directly
- Ask which vehicle, remaining allocation and decision timetable apply to the live round.
Investment lead
Early-stage decision-maker
Active says Tom Profumo leads its early-stage fund and is particularly interested in healthcare and education.
Partner · early-stage fund lead
Tom Profumo
Partner and early-stage fund lead — Joined Active in 2018 after consumer investment and corporate-finance roles; the official profile identifies healthcare and education as particular interests.
Track record + open questions
Public investment record
The public record is strongest on thesis, cheque ranges, team and named portfolio companies; live vehicle economics require confirmation.
What is publicly established
Active publishes distinct early-stage and growth criteria with £200,000–£1,000,000 and average £5,000,000–£15,000,000 cheque ranges.
Its 2024 review records 16 new investments and says healthier living and wellness accounted for 38% of that year's deals.
British Patient Capital's 1 April 2020 release documented a £30,000,000 commitment to Active Partners III, which closed at £100,000,000 in 2020. That is fund history, not a record of capital available today.
Companies House lists Active Partners Investments LLP as an active entity incorporated in 2004.
What to confirm for a live raise
Ask which vehicle, how much available capital and what remaining allocation by stage would apply to your round; the 2020 Active Partners III close does not answer that.
Stage criteria, cheque ranges, team and contact routes were last read on 31 August 2026; re-confirm them before approaching.
A portfolio listing shows the relationship but not ownership percentage, current valuation or a standardized company outcome.
The public approach describes support in broad terms; founders should agree governance, board involvement, reporting and operating support in the transaction documents.
Independent record
Fund and operating context
Independent and regulatory sources confirm the operating entity and the firm's last publicly documented fund close.
Independent and regulatory records
These records verify identity and the 2020 vehicle; they do not establish current available capital.
- British Patient Capital commits £30,000,000 to Active Partners IIIView source
British Patient Capital
Institutional investor announcement
1 Apr 2020
Companies House
UK company record
Record checked August 2026
Common founder questions
Frequently asked questions
Transparency
Transparency and sources
Researched by Longevity.io
- Reviewed
Company information
- Company information
- Investment approach
- Portfolio
- Team
- Investment lead
- Portfolio update
- Current activity
Independent and regulatory context
- Institutional investor announcement
- UK company record
Directory listings are for informational purposes only. Inclusion does not constitute endorsement. Verify credentials and qualifications independently.
Keep exploring
Build your starting plan.
A few short questions, about two minutes. The Blueprint recommends where to start and explains why.
Build my Blueprint